The success of these biologics in achieving disease remission has led to an increasing trend in their use in the overall population of people with autoimmune disease, 8 , 9 as well as in pregnant individuals, 10 , 11 , 12 with previous studies reporting biologic use in 5.7% of pregnant patients with an autoimmune condition. 12 However, evidence on biologic utilization patterns during pregnancy is incomplete.
← all excerpts
Use of Biologics During Pregnancy Among Patients With Autoimmune Conditions.
1
—
—